Andros Pharmaceuticals Co.,Ltd (6917.TWO)
TWD 14.95
(-18.31%)
TWD 14.95
(-18.31%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -241.89 Million TWD | -324.82% |
| 2022 | -56.94 Million TWD | -385.69% |
| 2021 | 19.93 Million TWD | -20.27% |
| 2020 | 24.99 Million TWD | 209.83% |
| 2019 | -22.76 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | -241.89 Million TWD | -324.82% |
| 2023 Q2 | -16.17 Million TWD | 71.59% |
| 2023 Q4 | -241.89 Million TWD | -1395.1% |
| 2022 Q4 | -56.94 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -213.967% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 8.432% |
| Level Biotechnology Inc. | -453.9 Million TWD | 46.708% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -100.625% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -23.165% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 148.393% |
| GlycoNex Incorporation | -148.56 Million TWD | -62.817% |
| VBI | -25.31 Million TWD | -855.495% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 700.738% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 275.291% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 7.879% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 891.069% |
| Visgeneer Inc. | 31.28 Million TWD | 873.216% |
| Mycenax Biotech Inc. | 207 Million TWD | 216.851% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 64.459% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -80.178% |
| Neith Corporation | -150.31 Million TWD | -60.928% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 138.919% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -319.531% |
| Enimmune corporation | -314.15 Million TWD | 23.003% |
| TaiRx, Inc. | -147.86 Million TWD | -63.586% |
| CHO Pharma, Inc. | -203.79 Million TWD | -18.696% |
| EirGenix Inc. | -4.58 Billion TWD | 94.728% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -185.376% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 300.125% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 92.484% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 23.794% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -1120.88% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 860.455% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 576.589% |
| RBC Bioscience Corporation | 422.18 Million TWD | 157.295% |
| BiOptic Inc. | 12.59 Million TWD | 2021.005% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 74.387% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -138.351% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -46.446% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 176.822% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -276.072% |
| NaviFUS Corp. | -123.12 Million TWD | -96.455% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 426.657% |
| Sinew Pharma Inc. | -160.34 Million TWD | -50.858% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 28.301% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 41.379% |
| AP Biosciences Inc | -196.52 Million TWD | -23.083% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 135.121% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -2015.004% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 70.845% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 117.821% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 41.695% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -15.551% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -68.141% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 26.819% |
| TCI GENE Inc. | -689.25 Million TWD | 64.905% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -103.377% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 81.524% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1280.945% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -137.453% |
| PharmaEngine, Inc. | -860.8 Million TWD | 71.899% |
| Savior Lifetec Corporation | -812.54 Million TWD | 70.23% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 19.36% |
| OBI Pharma, Inc. | -398.22 Million TWD | 39.257% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 33.804% |
| Acepodia, Inc. | -6.02 Billion TWD | 95.982% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 92.889% |